MRNA vaccine effective in treating glioblastoma brain cancer in small trial

The cancer vaccine is based on mRNA technology similar to that used in COVID-19 vaccines, but in this case a patient's own tumor cells are used to create a personalized vaccine, researchers said. Photo by Mitrey/Pixabay An experimental cancer vaccine can quickly reprogram a person's immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found. The cancer vaccine is based on mRNA technology similar to that used in COVID-19 vaccines, …